Quick Takeaways
- This page summarizes Jonathan Rubin's Form 4 filing for SUPERNUS PHARMACEUTICALS, INC. (SUPN).
- 6 reported transactions and 2 derivative rows are listed below.
- Filing timestamp: 30 Dec 2024, 16:13.
Jonathan Rubin - 27 Dec 2024 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)
- Signature
- /s/ Timothy C. Dec, as attorney-in-fact
- Issuer symbol
- SUPN
- Transactions as of
- 27 Dec 2024
- Net transactions value
- -$39,220
- Form type
- 4
- Filing time
- 30 Dec 2024, 16:13:12 UTC
- Previous filing
- 26 Dec 2024
- Next filing
- 29 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Jonathan Rubin filed Form 4 for SUPERNUS PHARMACEUTICALS, INC. (SUPN) on 30 Dec 2024."
What Changed
- Previous filing in this sequence was filed on 26 Dec 2024.
- Current net transaction value: -$39,220.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SUPN | Common Stock | Options Exercise | $0 | +750 | +15% | $0.000000 | 5,822 | 27 Dec 2024 | Direct | F1, F2 |
| transaction | SUPN | Common Stock | Tax liability | $10,001 | -281 | -4.8% | $35.59 | 5,541 | 27 Dec 2024 | Direct | F3 |
| transaction | SUPN | Common Stock | Options Exercise | $0 | +1,875 | +34% | $0.000000 | 7,416 | 27 Dec 2024 | Direct | F4 |
| transaction | SUPN | Common Stock | Tax liability | $29,219 | -821 | -11% | $35.59 | 6,595 | 27 Dec 2024 | Direct | F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SUPN | Performance Share Unit | Options Exercise | $0 | -750 | -100% | $0.000000 | 0 | 27 Dec 2024 | Common Stock | 750 | $0.000000 | Direct | F5 |
| transaction | SUPN | Performance Share Unit | Options Exercise | $0 | -1,875 | -100% | $0.000000 | 0 | 27 Dec 2024 | Common Stock | 1,875 | $0.000000 | Direct | F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023. |
| F2 | Includes an aggregate of 431 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
| F3 | Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| F4 | Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024. |
| F5 | On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023 and modified on December 12, 2024. |
| F6 | On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. |